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G-quadruplexin protecting genome stability, and their dysfunction contributes to cancer and
age-related degenerative diseases. The precise architecture of telomeres, including their single-stranded 3′
overhangs, bound proteins, and ability to form unusual secondary structures such as t-loops, is central to
their function and thus requires careful processing by diverse factors. Furthermore, telomeres provide unique
challenges to the DNA replication and recombination machinery, and are particularly suited for extension by
the telomerase reverse transcriptase. Helicases use the energy from NTP hydrolysis to track along DNA and
disrupt base pairing. Here we review current ﬁndings concerning how helicases modulate several aspects of
telomere form and function.
© 2009 Elsevier B.V. All rights reserved.1. Telomere biologyTelomeres are the repeated DNA sequences and associated proteins
that lie at the termini of linear chromosomes [1–3]. In most
eukaryotes, including all vertebrates, the telomere strand that extends
in a 5′- to -3′ direction toward the terminus is G-rich and ends with a
single-strand overhang. For example, vertebrate telomeres comprise
several kb of repeats of the sequence TTAGGG, and S. cerevisiae
telomeres comprise ∼350 bp of imperfect repeats with the consensus
(TG)0–6TGGGTGTG(G) [4,5]. Like soldiers on the front lines of a battle,
telomeres are critical to the protection and stability of internal
chromosome sequences, a function known as telomere “capping”. In
capping chromosome ends, telomeres restrict end resection by
exonucleases and also prevent the improper activation of checkpoint
response factors and DNA damage response pathways such as
homologous recombination (HR) and non-homologous end joining
(NHEJ). In order to perform such a myriad of tasks, telomeres are
endowed with a special type of armor that helps camouﬂage and
protect them, even enabling them to subvert to their own ends the
actions of potential foes, such as exonucleases and DNA damage
response factors. In vertebrates, the core of this capping armor is
called shelterin, a complex of proteins including (among others) thed Laboratory Medicine, 405A
delphia, PA 19104-6100, USA.
. Johnson).
ll rights reserved.Myb-type homodomain proteins TRF1 and TRF2, which bind the
duplex form of the telomere repeats, and the OB-fold containing
protein POT1, which binds the single-stranded telomere overhang [3].
A similar arrangement is present in most other eukaryotes. For
example, in the yeast S. cerevisiae the Myb-type homodomain protein
Rap1 binds the duplex telomere repeats, and the OB-fold protein
Cdc13 binds the 3′ overhang [6]. Remarkably, even factors such as ATM
and Ku, which normally respond to the DNA termini exposed during
double strand breaks by activating cell cycle checkpoint responses and
initiating repair to rejoin the breaks, are enlisted by shelterin to
instead helpmaintain telomere structure and function [7–10]. Inmany
organisms (though apparently not in S. cerevisiae) telomeres can form
a loop structure, called a t-loop (Fig. 1A), in which the 3′ end of the
single stranded overhang invades at the base of the telomere repeats
to form a D-loop [11,12]. Correlative evidence indicates that t-loops
may be a critical component of the cappingmechanism [13–15], but as
described below, they may also present challenges to telomere
replication and induce recombination-based deletion events. In
addition, evidence is accumulating that another non-canonical set of
structures called G-quadruplexes can form among telomere repeats.
G-quadruplexes are stacked associations of G-quartets, which are
themselves planar assemblies of four Hoogsteen-bonded guanines,
with the guanines derived from one or more nucleic acid strands
[16,17]. The formation of such secondary DNA structures may also
pose special problems for telomere maintenance, because their
resolution would be necessary for the efﬁcient completion of DNA
replication (Fig. 1B–C).
Fig. 1. Potential secondary structures at telomeres. (A) Through the assistance of TRF2 and perhaps other factors, the 3′ overhang loops back and invades into internal telomere
repeats forming a t-loop. This is thought to help protect the telomere terminus from further exonucleolytic processing and to prevent it from inappropriately activating checkpoint
proteins. (B) The general structures of a G-quartet (left) and of an intramolecular G-quadruplex (right) are shown. (C) Illustration of a G-quadruplex that has formed at the 3′
overhang, although it is possible that G-quadruplexes also form among internal telomere repeats, particularly under conditions where they become single-stranded, e.g. replication
and recombination.
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replication machinery is incapable of fully copying the ends of linear
molecules, but also due to resection by exonucleases, oxidative
damage and inappropriate recombination events [18]. Telomerase, a
reverse transcriptase that carries its own RNA template which codes
for telomere repeats, can lengthen telomeres and thus counteract
telomere shortening [2]. However, most human cells lack sufﬁcient
telomerase to maintain telomere length, and so their telomeres
gradually shorten. When telomeres shorten to a critical length,
telomeres become uncapped, which can lead to permanent cell
cycle arrest (termed cellular senescence) or apoptosis, depending on
the cellular context in which the uncapping occurs [19]. Telomere
shortening clearly limits the replicative lifespan of many different
human cells in culture, including ﬁbroblasts and vascular endothelial
cells, because the artiﬁcial expression of telomerase can effectively
immortalize these cells [20–22]. Telomeres shorten with age in many
human tissues, including skin, kidney, liver, pancreas, blood vessels
and leukocytes in peripheral blood [23,24].
Much evidence supports the idea that short telomeres contribute
to age-associated pathology. For example, individuals over the age of
60 who have telomeres in the bottom half of telomere length
distribution have 1.9-fold higher mortality rates than age-matched
individuals with telomere lengths in the top half of the distribution,
and telomere length is heritable and associated with parental lifespan
[25,26]. Similarly, increased telomere length is correlated with
improved left ventricular function and reduced cardiovascular
disease risk, improved bone density and oocyte function, and reduced
poststroke mortality and dementia [27–31]. Particularly short
telomeres and markers of cell senescence are present at sites of
pathology, including atherosclerotic vessels and cirrhotic liver
nodules [32,33]. Because short telomeres are associated with age-
related pathology, it is not surprising that telomerase deﬁciency also
correlates with age-related disease. For example, individuals with
dyskeratosis congenita, who have a ∼50% decrease in telomeraseactivity, suffer from several age-associated pathologies such as bone
marrow failure and osteoporosis [34]. Similarly, people with other
hypomorphic mutations in telomerase, or short telomeres in the
absence of an apparent telomerase mutation, are at increased risk for
bone marrow failure, pulmonary ﬁbrosis and liver cirrhosis [35–38].
In addition, several lines of evidence (described below) indicate that
telomere defects contribute centrally to the pathogenesis of the
Werner premature aging syndrome [39–42], and shortened telo-
meres are found in other progeroid syndromes including Hutch-
inson–Gilford progeria (HGP) and ataxia telangiectasia [43]. The
artiﬁcial overexpression of telomerase has recently been shown to
reverse some of the cellular effects of the altered form of lamin A,
called progerin, that causes HGP [44], which is consistent with the
idea that telomere dysfunction contributes to pathogenesis in this
disease. The development of the “TIF” (telomere dysfunction induced
foci) assay that is based on colocalization of the DNA repair factors
53BP1 and γH2AX with uncapped telomeres has begun to allow
measurement of telomere uncapping in aged tissues [45–48].
Remarkably, TIF+ nuclei increase exponentially with age in baboon
dermis, are associated with markers of cell senescence, and are found
in approximately 20% of dermal ﬁbroblasts in the oldest individuals
[49,50]. Finally, telomere shortening appears to play important roles
in cancer, a major age-related disease, where it both limits the
progression of precancerous lesions into mature tumors and, at the
same time, can contribute to genome instability in the rare neoplastic
cells that progress through the proliferative barriers set by telomere
attrition [51,52]. Although deﬁnitive proof that improved telomere
maintenance will mollify age-related disease is currently not
available, there is good evidence that telomeres play an important
role in human age-related diseases. Thus, efforts to understand
mechanisms of telomere maintenance and dysfunction are expected
to contribute to our understanding of the natural aging process and
hopefully will provide targets for ameliorating diseases of aging,
including cancer.
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Helicases catalyze the hydrolysis of nucleotide triphosphates
(typically ATP) and convert this chemical energy into mechanical
energy that enables the separation of base-paired strands of nucleic
acids [53,54]. One example of this is the “melting” of duplex DNA into
its constituent single strands. All DNA helicase monomers have a pair
of adjacent RecA-like domains that create a site for NTP binding and
hydrolysis at their interface and participate together in nucleic acid
binding. Cycles of nucleotide binding, hydrolysis, and release drive
structural changes in the helicase that lead to its movement along the
nucleic acid substrate and ultimately to strand separation. Helicases
can differ in their substrate speciﬁcity (e.g. DNA vs. RNA; requirement
for single strand overhangs for loading), directionality of translocation
(5′-to-3′ or 3′-to-5′ along the bound strand), ability to translocate
along single vs. duplex substrates, oligomeric structure (e.g. mono-
meric vs. hexameric), processivity, and their ability to do more than
simply separate strands (e.g. to displace bound proteins from DNA).
Helicases are currently classiﬁed into six superfamilies, SF1-6, based
largely on conservedmotifs within their NTP and DNA binding regions
[54]. The N- and C-terminal protein sequences that usually ﬂank the
“core” catalytic helicase domain add additional layers of complexity to
helicase function by determining substrate speciﬁcity (e.g. the HRDC
domain within RecQ family members), providing binding sites for
cooperating proteins (e.g. topoisomerase IIIα binding to BLM), or
adding novel catalytic activities (e.g. the nuclease domains present in
the archaeal Hef or mammalian WRN proteins) [55,56]. Different
helicases are thus endowed with tools to facilitate different aspects of
telomere maintenance and function. The importance of helicases for
human health is underscored by the several genome instability
diseases that can be caused by helicase deﬁciencies, including the
Werner and Bloom syndromes, Fanconi anemia, Cockayne syndrome,
xeroderma pigmentosum, and tricothiodystrophy [57]. Helicases are
part of a larger family of nucleic acid translocases, the other members
of which do not couple their motion to strand separation [54]. These
other enzymes are structurally and mechanistically very similar to
helicases, and some even play important roles in telomere and
telomerase regulation (e.g. Pontin, Reptin [58]), but the scope of this
review is limited to bona ﬁde helicases.
3. Helicase functions at telomeres
The specialized characteristics of telomeres outlined above begin
to explain why helicases play important roles in their maintenance.
Helicase functions at telomeres can be divided into those serving in
replication, end processing and capping, telomerase-mediated exten-
sion, telomere chromatin remodeling, responses to uncapped telo-
meres, and recombination-dependent maintenance of telomeres.
Each of the following sections will describe a particular telomere
function and brieﬂy discuss any helicases that appear to play a role
restricted to that particular function. Helicases with roles in multiple
telomere functions will then be examined in more detail further
below.
3.1. Telomere replication
Telomeres provide several challenges to the DNA replication
machinery [9,59–61], and helicases may help overcome these
obstacles. First, telomeres are bound by proteins that might impede
the progression of replication forks, and a helicasemoving ahead of the
fork could help remove these proteins. Importantly, it isn't yet clear to
what extent particular telomere proteins inhibit or promote replica-
tion, because although some, e.g. TRF1, have been shown to impede
replication in an in vitro system and perhaps in vivo, others, e.g. the
S. pombe TRF1/2 homologue Taz1, actually facilitate telomere rep-
lication in vivo [62,63]. Second, telomere DNA can itself formsecondary structures, such as t-loops or G-quadruplexes (Fig. 1), that
might impede forks in away that could be relieved byhelicases capable
of unwinding such structures [61]. Third, because replication initiates
from origins, and not from DNA ends, replication ought to proceed
unidirectionally from subtelomeric origins toward the telomere
terminus. This has been demonstrated directly in S. cerevisiae [59,64],
and is probably also true for higher eukaryotes (although there are
intriguing hints that replication might conceivably be able to initiate
within telomere repeat DNA in mammalian cells [65]). Such unidirec-
tional replication prevents rescue of a collapsed replication fork by one
approaching from the opposite direction, and therefore collapsed
telomere forks must either be restarted or telomere loss events will
occur. There are several mechanisms by which stalled forks can be
stabilized and then enabled to replicate past damaged templates or by
which collapsed forks can be restarted, and there is evidence for
helicase functions in each of these [66–71]. For example, stalled or
collapsed forks can either a) undergo reverse branchmigration to form
a “chicken-foot” structure, b) engage in HR-mediated template
switching to bypass an inhibitory lesion, or c) undergo cleavage
followed by invasion of the broken end into the intact duplex to form a
new fork (Fig. 2).
3.2. Telomere end processing
The replicationproducts of both leading and lagging strand synthesis
at telomeres require processing to generate the 3′ G-rich overhangs,
which are ∼12–14 nt and ∼50–200 nt in length in S. cerevisiae
and in human cells, respectively (Fig. 3). The product of leading strand
synthesis is presumably a blunt ended (or 5′ overhang-containing)
duplex, and so to produce the necessary 3′ overhang, processing of the
C-rich strand by nucleases must occur. The nuclease(s) performing
this task remain largely unidentiﬁed, although an exception may be
Mre11, which is required to generate full overhang length in S. cerevisiae
[72]. However, it isn't clear whether its nuclease activity or its
other functions within the Mre11/Rad50/Xrs2 complex is involved.
Furthermore, the fact that a similar requirement for MRE11 for full
overhang length in human cells is dependent on telomerase suggests
that extension of the overhang by telomerase, rather than resection of
the C-rich strand, is the key Mre11-dependent process [72,73].
Regardless, it is clear that telomere overhangs exist independently of
telomerase [74,75], and helicases could facilitate resection of the C-rich
strand by nucleases to establish these overhangs. The product of lagging
strand synthesis at telomeres naturally has a 3′ overhang because even
if the ultimate RNA primer of lagging strand synthesis were to begin at
the telomere terminus, a gap would remain after its removal;
furthermore, there is some evidence in human cells indicating that
the ﬁnal RNA primer does not lie at the terminus [61]. In either case,
helicase activity could still be involved in processing the lagging strand
product, because the normal mechanism of RNA primer displacement
by encroaching DNA polymerase δ does not exist at the terminus, and a
helicase could substitute to help displace the primer so that the newly-
exposed lagging strand product could be cleaved by nucleases such as
FEN1 and DNA2 [76].
3.3. Telomerase regulation
To extend the single-stranded G-rich 3′ telomere overhang,
telomerase must ﬁrst base pair part of its internal RNA template
with the single-stranded telomere terminus. Telomerase activity at
the telomere can therefore be inhibited if the overhang adopts
secondary structures that inhibit such pairing, such as t-loops or
G-quadruplexes [16]. By unwinding such secondary structures,
helicases could stimulate extension of telomeres by telomerase. In
contrast, helicases tracking along the telomere overhang could also
displace telomerase and thus inhibit telomere extension [77]. Finally,
there is some evidence that the telomerase template RNA itself can
Fig. 2. Examples of helicase-assisted mechanisms of replication fork rescue. (A) A replication fork stalls or collapses at an inhibitory lesions (black dot). The replication fork can then
regress via reverse branch migration to form a “chicken foot” structure, followed by copying of the newly synthesized sister strand to generate sequence beyond the lesion.
Dissolution of the regressed chicken foot occurs by reverse branch migration, and replication resumes. Helicases could be involved at the branch migration steps. (B) A lesion that
blocks replication is bypassed by a switch in template from the parental strand to the newly replicated sister chromatid. Once the lesion has been bypassed, reinvasion back to the
parental template can occur, and then resolution of entwined strands allows the sister chromatids to separate. Helicases could assist in the original template switch, the reinvasion
step, and the ﬁnal resolution step. (C) If a collapsed fork leads to a double strand break, resection of the broken DNA end to generate a recombinogenic 3′ end allows invasion of the
intact chromatid and resumption of DNA synthesis. Branch migration of the D-loop (to the left) establishes a full Holliday junction, thus allowing the resumption of replication.
Helicases could assist in end-processing, invasion and branch migration.
Fig. 3. End-processing of telomeres after replication. The G-rich strand is replicated by lagging strand synthesis, and evenwith fully efﬁcient lagging strand synthesis the removal of
the terminal RNA primer allows for the generation of a 3′ overhang. Helicases could assist with RNA primer removal and might also aid with additional nucleolytic processing.
The C-rich strand is replicated via leading strand synthesis and therefore for the 3′ overhang to be generated, the activity of exonucleases and/or endonucleases such as theMre11 are
required, which could be assisted by helicases.
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helicases might regulate telomerase activity by unwinding such
secondary structures.
3.4. TERRA and telomere chromatin
Telomeres bear several marks of heterochromatin and can repress
transcription from subtelomeric promoters [79]. Somewhat surpris-
ing, then, are the recent demonstrations that the telomere repeats are
transcribed by RNA polymerase II in human, murine, and S. cerevisiae
cells [80–82]. The RNA products, called TERRA (telomere repeat-
containing RNA), are primarily transcribed from the C-rich strand and
are thus themselves G-rich. TERRA molecules are nuclear and
associate with telomere chromatin. Increased association correlates
with telomere loss events in human cells and inhibits extension of
telomeres by telomerase in yeast [80,81]. How TERRA associates with
telomeres has not been characterized, and although telomere proteins
may certainly be involved, another intriguing possibility is that
intermolecular RNA–DNA G-quadruplexes or G-loops (in which an
RNA–DNA duplex between TERRA and the telomere C-rich strand
would be stabilized by G-quadruplex formation on the displaced
G-rich strand [83]) help mediate the interaction [61,84]. In mammals,
TERRA is dissociated from the telomere by the UPF15′–3′ RNA helicase
[81], which is part of the nonsense-mediated mRNA degradation
pathway, but the mechanism of dissociation is unknown. Similar
inhibition of TERRA-telomere association has not yet been demon-
strated for yeast Upf1, but upf1Δ mutants have shortened telomeres,
consistent with such a role [85]. TERRA levels are decreased in several
types of cancer [82], raising the possibility that TERRA might be a
useful target for cancer therapeutics. However, the potential func-
tional roles of TERRA in cell senescence, carcinogenesis and cancer
growth are untested.
3.5. Processing uncapped telomeres
Perturbation of the proteins that compose telomere chromatin or
critical shortening of the telomere repeat DNA can each cause
telomeres to uncap. Examples are yeast cdc13-1 mutants, which
upon shifting to a non-permissive temperature, lose Cdc13-dependent
capping [86], and eukaryotic cells in which telomerase is either
naturally absent or has been genetically disabled and which are then
allowed to divide to the point of telomere shortening [45,48]. Once
telomeres become uncapped by these manipulations, nucleolyticFig. 4. Depictions of the non-homologous end joining (NHEJ) and single-strand annealing (S
back together. (B) In SSA, nucleolytic processing of DNA ends (perhaps dependent upon RecQ
of DNA breaks. The non-homologous 3′ ﬂaps are removed by nucleases, such as Rad1/10, wresection of the C-rich strand leads to single strand DNA accumulation,
which helps activate checkpoint responses [86,87]. Exonuclease I is a
key player, because both yeast and murine cells lacking Exo1 have
reduced ssDNA generation at uncapped telomeres [86,88,89]. At
generic DNA duplex ends, exonuclease activity can be stimulated by
DNA helicases, including the RecQ family helicases Sgs1 and BLM (see
below) [90–92]. This is presumably because DNA secondary structures
or bound proteins, which can be removed by helicases, impede
exonuclease progression. Similar helicase-mediated stimulation of
telomere end-resection may also occur, although the telomere DNA
and protein structures may affect certain details, such as which
helicases are most important.
3.6. Telomere recombination
Uncapped telomeres can be engaged by DNA repair pathways,
including NHEJ and different subpathways of HR. One possible
outcome is telomere end-to-end fusions, which are of particular
importance in carcinogenesis [93,94]. This is because any incipient
cancer cells that manage to pass through the barriers of apoptosis or
cell senescence imposed by critically shortened telomeres can emerge
from these barriers with aneuploidy caused by chromosome fusion-
bridge-breakage events that arise from telomere fusions. Telomere
fusions mediated by NHEJ are not known to be affected by helicases.
However, fusions in S. pombe induced by genetic inactivation of Pot1
were found recently to result from single-strand annealing (SSA)
rather than NHEJ [95]. SSA is a type of HR that involves base pairing of
complementary 3′ ssDNA ends generated by 5′-to-3′ end resection
(Fig. 4). The telomere fusions described in S. pombe pot1− mutants
were found to require the 5′-to-3′ helicase Srs2, which is required
generally for SSA involving long non-homologous 3′ tails [96].
Unexpectedly, they also required the 3′-to 5′ RecQ-family helicase
Rqh1, which might function in this setting to unwind secondary
structures formed by single-strand telomere repeats, such as G-
quadruplexes, or to exonucleolytically process the DNA ends (see
below). In contradistinction to mechanisms that lead to fusions, HR
pathways different from SSA can support telomere length main-
tenance in the absence of telomerase. Examples are mechanisms
supporting telomere maintenance in yeast telomerase mutants that
have escaped the death that occurs in most cells due to telomere
shortening, thus forming so-called “survivors”, and in some types of
telomerase-negative human tumors, classiﬁed as “ALT”, for alternative
lengthening of telomeres [97]. In simple terms, HR-dependentSA) pathways of DSB repair. (A) In NHEJ, double strand breaks are essentially re-ligated
-family helicases) occurs, and regions of homology are utilized to help guide the ligation
hich can be assisted by the Srs2 helicase when the ﬂaps are long.
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telomere that in turn serves as a template to direct DNA synthesis and
thus elongation of the shortened telomere. The many interesting
details of such events are reviewed elsewhere [97,98]. There is also
evidence that HR mechanisms help maintain telomeres in dividing
cells lacking telomerase as well as cause telomere lengthening in
preblastoderm mouse embryos [99–101]. Further, as discussed below,
helicases in the RecQ family play important roles in HR-dependent
telomere maintenance.
4. Helicases with diverse activities at telomeres
4.1. RecQ-family
The RecQ family of proteins are SF2-type helicases that track along
ssDNA with 3′-to-5′ polarity, and their structure and functions have
been reviewed recently [57,71,102]. They are among the most studied
helicases because loss-of-function mutations in three of the ﬁve
human RecQ family proteins, WRN, BLM and RecQ4, lead to the
Werner, Bloom and Rothmund–Thomson genome instability syn-
dromes, respectively (WS, BS and RTS). Although these diseases are
very rare, they are of broad interest because they are characterized by
elevated rates of cancer and premature features of aging, particularly
in the cases of BS and WS, respectively. Studies of the human proteins
and of their homologues in model organisms have provided evidence
for their involvement in several aspects of DNAmetabolism, including
regulation of homologous recombination, replication, base-excision
repair, transcription, and intra-S phase checkpoint responses. Of note,
RecQ4 might not be an actual helicase, because the puriﬁed protein
apparently lacks helicase activity in vitro, although it does possess
ATPase and ssDNA annealing activities [103]. It will be important to
determinewhether cofactorsmight enable RecQ4 helicase activity, if it
is perhaps active in unwinding substrates different from those tested,
or if it instead functions in a different capacity, e.g. as a translocase.
Many RecQ-family helicases are particularly adept at unwinding non-
canonical DNA substrates. Substrates deﬁned in vitro include forked
duplexes and replication forks, bubbles, X-structures, double Holliday
junctions, D-loops, and G-quadruplexes [104–112]. WRN, BLM and
Sgs1, but not RECQ1, unwind G-quadruplexes [108–111,113]. Moreover,
direct substrate competition experiments indicate that Sgs1 and BLM
are approximately an order of magnitude more active in unwinding
G-quadruplexes than other favored substrates [111]. Similarly, the
kinetics of G4-DNA unwinding by WRN and BLM are greater than for
other substrates [107]. Also of note, the WRN protein distinguishes
itself from the rest of its family by containing a 3′-to-5′ dsDNA-
dependent exonuclease domain ensconced near its N-terminus
[114,115]. Several RecQ family helicases have been shown to function
at telomeres, including mammalian WRN and BLM, S. cerevisiae Sgs1,
and S. pombe Rqh1 and Tlh1.
A role forWRN in telomeremaintenancewas ﬁrst suggested by the
premature senescence and elevated telomere shortening rates of
cultured ﬁbroblasts from individuals with WS [116,117]. The partial
localization of BLM at telomeres and the capacity of overexpressed
BLM to lengthen telomeres in ALT cells, which use telomere
recombination rather than telomerase to maintain telomere lengths,
indicated that BLM also can function at telomeres [118,119]. Studies of
the WRN and BLM homolog Sgs1 in yeast then demonstrated that in
cells lacking telomerase, this RecQ family helicase helped slow
senescence and also facilitated the formation of ALT-like recombina-
tion-dependent survivors of telomere shortening [120–122]. The
partial localization of WRN to telomeres in ALT and telomerase-
positive cells also supported a telomere role, as did demonstrations
that TRF2 binds WRN and BLM directly [119,122–125]. One additional
and particularly fascinating line of evidence came from studies of the
smut fungus U. maydis and yeast S. pombe, where RecQ family helicase
genes are located at subtelomeric regions [126,127]. Genes locatednear telomere ends are subject to reversible transcriptional repression,
referred to as telomere position effect (TPE), which has been shown to
occur in a wide range of eukaryotes from S. cerevisiae to mice and
humans [79,128,129]. Although their transcription is repressed inwild
type cells, which possess telomerase, when telomeres shorten in the
absence of telomerase, the transcript levels of these subtelomeric RecQ
genes are increased, raising the possibility that these helicases may
have important roles in the emergence of telomerase-independent
survivors. Indeed data supporting this notion come from S. pombe
where the overexpression of the native or an apparent dominant-
negative form of the putative RecQ-related helicase Tlh1 (SPAC212.11)
leads to a swifter or delayed recovery from critical telomere shortening
in telomerase mutants, respectively [126]. Of note, a non-RecQ-family
helicase, Y′-Help1, is positioned at similar subtelomeric positions in S.
cerevisiae and is highly expressed in cells with critically shortened
telomeres [130]. In normal cells, the subtelomeric locale of these
helicases might enable cells to use HR to repair a telomere that has
been suddenly and critically shortened by DNA damage.
The WRN protein has many apparent functions, but knowing which
is of central importance for driving the humanWS phenotype is difﬁcult
because all people with WS appear to have null alleles [131], thus
preventing mapping of domains with particular biochemical functions
to the disease phenotypes. However studies in mice argue for a
particularly important role of WRN at telomeres. Mice lacking WRN
are relatively (though not completely) unaffected, and this may be
because the longer telomeres andmore abundant telomerase activity in
mice, relative to in humans, mask the telomere defects that might
otherwise occur in the absence of WRN (because a telomere loss event
caused by WRN deﬁciency could be repaired by telomerase) [132,133].
However, when telomerase is inactivated genetically (in mTerc−/−
mutants, which lack the telomerase RNA template), a clear role forWRN
in mice becomes apparent, and the mTerc−/− and Wrn−/− mutations
synergize to cause degenerative pathologies inmany tissues [39,41,134].
This may explain why most degenerative pathologies in WS lie in
mesenchymal tissues, where telomerase expression is at its lowest, thus
allowing any telomere defect caused by WRN deﬁciency to have a
profound effect. In mice, Blm deﬁciency has an even greater effect on
pathology in combinationwithmTerc deﬁciency than doesWrndeletion
[39]. However, in humans with BS, a telomere defect may be less
relevant to pathology because BLM expression is most prominent in
tissues, such as lymphocytes, that can express high levels of telomerase,
which could repair telomere lesions that might be caused by BLM
deﬁciency [39,135]. We want to emphasize that while degenerative
pathologies might be signiﬁcantly impacted by telomere dysfunction in
WS, and perhaps BS, it is likely that the elevated rates of malignancies in
these syndromes are caused by widespread genome instability at
regions outside the telomere, presumably related to roles for WRN and
BLM in DNA recombination, replication fork stabilization and DNA
damage checkpoint responses [136–138]. Nonetheless, evidence for an
unexpectedly signiﬁcant role for telomere dysfunction in driving
widespread genome instability in WS cells has been reported [42].
How do RecQ-family helicases affect telomere metabolism? Based
on the available evidence, a challengingly large number of potential
mechanisms appear to exist. While not mutually exclusive, it seems
likely that only a few will prove to be of primary importance.
Elegant biochemical studies using puriﬁed WRN and deﬁned
substrates implicate the helicase in reactions that could encourage
replication fork progression at telomeres including 1) enhancement
of DNA polymerase delta processivity [139–141], 2) stimulation of
translesion synthesis by direct stimulation of translesion poly-
merases or by unwinding secondary structures formed at stalled
forks [67,142], and dissolution of 3) t-loops or 4) G-quadruplexes
which might form at telomere ends [40,107,108,110,125,143,144].
t-loops and G-quadruplexes could each impede replication fork
progression, and POT1 could facilitate unwinding of either because
it stimulates WRN (and also BLM) helicase activity and may be bound
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itself inhibits G-quadruplex formation by binding to the single-
stranded conformation [144–146]. TRF2 could also be involved in
t-loop unwinding because it binds and stimulates the helicase activity
of WRN (and BLM) [123]. TRF2 induces positive DNA supercoiling and
thus presumably binds positively supercoiled DNA more tightly than
relaxed DNA. TRF2 could therefore accumulate at the positive
supercoils created in front of advancing replication forks that are
topologically constrained by a t-loop and then stimulate WRN to
remove the t-loop, thus enabling the fork to advance further [61,147].
In vitro studies suggest that WRN exonuclease activity may also help
dissolve t-loops by degrading the telomere 3′ overhang that is
inserted at the base of the t-loop [125,143]. Thus the combined
actions of WRN helicase and exonuclease activities may make it
particularly well suited to removing these potential impediments to
telomere replication. Finally, 5) WRN may play a role in resolving
intermediates generated by template-switching mechanisms that
enable replication forks to bypass stall-inducing lesions [67]. In vivo
studies provide some support for each of these ﬁve models. Models 1
and 2 are supported by studies showing that replication fork
progression is impaired in WS cells on a genome-wide level,
particularly under conditions of replication stress, although the extent
to which this applies to telomeres is unknown [148,149]. There is no
direct in vivo support for model 3, even though it is quite plausible.
However, there is some evidence that may bear on this issue. WRN
appears to modulate the generation of t-circles, which are circular
duplexes comprising telomere repeats [150]. WRN reportedly
enhances an HR-dependent form of t-circle genesis caused by
expression of the mutant form of TRF2 lacking its basic domain
(TRF2ΔB) [151] (although the original study did not observe a clear
requirement for WRN [150]). One model for t-circle formation
involves a modiﬁed t-loop that contains a double HJ (Fig. 5). When
such a structure is resolved so that a crossover occurs, the circle can be
deleted from the ends [152]. WRN might help form the double HJ
t-loop by catalyzing branchmigration of a standard t-loop. In contrast,
WRN prevents HR-independent t-circle formation [151], conceivably
by preventing replication-associated breaks that could occur if t-loops
are not unwound. Model 5 is supported by studies showing that WRN
promotes cell survival and resolves HR intermediates [153,154], and by
the demonstration that Sgs1 prevents rapid telomere loss by resolving
replication-associated HR intermediates at telomeres [101,155]. It is
also possible that WRN functions at G-quadruplexes forming on
single-stranded regions of telomere HR intermediates, thus unifying
mechanisms 4 and 5. A remarkable study by Jan Karlseder's group
demonstrated a role for WRN in preventing rare telomere loss events
occurring preferentially at the products of lagging strand synthesis,
called sister telomere losses (STL) [40]. WRN helicase, but notFig. 5. t-loop dynamics. A standard t-loop might be unwound by a helicase (e.g. WRN or BL
working together with HR factors, could allow a t-loop to branch migrate to form a double
concerted action of nucleases), this could lead to telomere truncation and t-circle formation.
sequences and could thus dissolve a double HJ t-loop. Also, because a double HJ t-loop is n
migration.exonuclease, activity prevents STL. Because telomere replication
initiates from an internal origin, lagging strand synthesis occurs on
the G-rich template, and so this raised the possibility that an inability
of WS cells to resolve G-quadruplexes, or to remove proteins bound to
other telomere-speciﬁc structures, such as Pot1 from the G-rich strand
of a t-loop, during telomere replication explains the defect. However
direct evidence for these ideas remains to be demonstrated. None-
theless, two recent ﬁndings in S. cerevisiae suggest in vivo roles for
G-quadruplexes that involve a RecQ helicase and telomeres. First, the
genes that have altered expression in sgs1 mutants are preferentially
those with the potential to form intramolecular G-quadruplexes,
arguing that Sgs1 can regulate gene expression by unwinding
G-quadruplexes [156]. Second, a screen of all viable haploid deletion
mutants for those conferring enhancement or suppression of growth
inhibition by the selective G-quadruplex ligand N-methyl mesopor-
phyrin IX revealed a set of mutants that was signiﬁcantly enriched for
telomere maintenance factors, indicating that G-quadruplexes affect
telomere function in yeast [156]. Also of interest, telomere chromatin
appears to play an important role in telomere maintenance by WRN
because human cells deﬁcient in the SirT6 histone H3K9 deacetylase
are unable to recruit WRN to telomeres and have elevated rates of
STL [157].
RecQ helicases play important roles in HR-dependent telomere
maintenance, as noted above. BLM activity extends telomeres in
human ALT cells, Tlh1 promotes survival in S. pombe lacking
telomerase, and Sgs1 enables the formation of one form of telomer-
ase-independent survivor in S. cerevisiae [119,122,126]. The Sgs1-
dependent survivors are called type II and have ampliﬁed telomere
repeat tracts of variable length similar to human ALT cells; this
contrasts with type I survivors which are Sgs1-independent and have
ampliﬁed subtelomeric sequences. In contrast to the pro-telomere HR
functions of BLM, Tlh1, and Sgs1 there is evidence for inhibition of ALT
by WRN, because cultured murine mTerc−/− Wrn−/− ﬁbroblasts
apparently adopt an ALT phenotype more readily than mTerc−/−
Wrn+/+ controls [158]. Consistent with this ﬁnding, the double
mutant cells also displayed higher rates of telomere sister chromatid
exchanges and of telomere double-minute chromosome formation.
Increased telomere recombination help explain the elevated incidence
of mesenchymal tumors in WS, because such tumors in normal
individuals are particularly prone to using an ALT mechanism of
telomere maintenance [97,159]. It would be interesting to test if WS
mesenchymal tumors have a particularly high prevalence of ALT. On
the other hand, WRNmight sometimes promote, rather than inhibit, a
standard ALT phenotype because one ALT cell line derived from an
individual with WS and then immortalized with SV40 T-antigen has a
telomere structure similar to type I yeast survivors, although the
contribution of the Wrn mutation to the phenotype has not beenM) to facilitate replication of the telomere. In addition, a helicase (e.g. WRN), perhaps
HJ at its base. If resolved with crossing over (e.g. by a classical HJ resolvase or by the
BLM, together with Topo IIIα, can resolve a double HJ in the middle of extensive ﬂanking
ear an end, other helicases, such as WRN may be able to remove it by simple branch
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yeast to enable type II survivors to form [120,161]. The distinction
between a clear stimulation of HR-dependent telomere maintenance
by BLM and Sgs1, and inhibition or less robust stimulation by WRN,
might be explained by the association of the ﬁrst two helicases with
topoisomerase III, which does not interact with WRN [162–164]. Yeast
top3Δ mutants fail to form type II survivors of telomerase deletion,
and downregulation of topoisomerase III alpha interferes with ALT in
human cells [165,166]. Perhaps the combined action of a helicase with
the strand-passage activity of a topoisomerase III protein facilitates
efﬁcient resolution of telomere recombination intermediates.
A newly recognized function for Sgs1 and BLM that is likely to be
important at telomeres is the stimulation of 5′-to-3′ exonucleolytic
end resection of duplex DNA ends. At breaks induced by the HO
endonuclease, Sgs1 helicase activity stimulated end-resection by
approximately four-fold, and the target of stimulationwas found to be
the Dna2 exonuclease [90–92]. Dna2 also possesses helicase activity
itself, but this is dispensable for its end-resection activity [92]. In
human cells siRNA-mediated knockdown of BLM diminished the
appearance of ssDNA after camptothecin treatment, as assessed by the
phosphorylation of, and nuclear focus formation by, the RPA single-
strand DNA binding complex [90]. Sgs1/Dna2 and BLM appear to
function at breaks largely in parallel with yeast Exo1 and human EXO1,
respectively. However, the direct binding of EXO1 to WRN, as well as
the stimulation of EXO1-mediated cleavage by WRN, suggest that
RecQ helicases can also function together with Exo1/EXO1 [167].
Recently sgs1 deletion was found to allow yeast cells lacking both
telomerase and HR (e.g. tlc1 rad52 mutants, which otherwise die
because they cannot maintain telomeres) to grow indeﬁnitely despite
the eventual loss of telomere sequences [168]. Slowed end-resection
might explain this observation because exo1 deletion has a similar
effect [168,169]. These ﬁndings raise the possibility that some of the
functions of RecQ-family proteins in telomere HR stem from a role in
generating recombinogenic 3′ single-stranded ends, instead of, or
more likely in addition to, resolving HR intermediates. Moreover, it is
possible that RecQ helicases might inﬂuence the exonucleolytic
processing of telomere ends, for example after replication or upon
telomere uncapping. The suppression of telomere loss by deletion of
the Rqh1 RecQ-family helicase in S. pombe mutants with telomere
protection defects (taz1-d rad11-D223Y double mutants, which lack
the Taz1 telomere repeat binding factor and have a hypomorphic form
of RPA) is consistent with the latter possibility [170]. Precisely how
Sgs1 and BLM stimulate end-resection is unknown, but a reasonable
possibility is that they remove DNA secondary structures that could
impede exonuclease progression. G-quadruplex or other secondary
structures formed at telomeres might thus make resection of
telomeres particularly dependent on aid from helicases. Another
possibility is that RecQ helicases might unwind telomere ends to
reveal a 5′ ssDNA ﬂap that could be cleaved by endonucleases like
Dna2 or FEN1 [170]. Consistent with this possibility, WRN and BLM
each bind and stimulate the nuclease activity of FEN1 [171–173].
Remarkably, defects in telomere replication via lagging but not leading
strand synthesis caused by knockdown of FEN1 led to STL events
similar to those observed in WS cells [174]. An allele of FEN1 that
disrupts its interaction with WRN did not rescue the STL, arguing for
the importance of the WRN-FEN1 interaction. However, inhibition of
STL by WRN requires its helicase activity [40], whereas stimulation of
FEN1 is independent of WRN helicase activity [172], and thus the
precise contributions of each protein, and their cooperative interac-
tion, to the suppression of STL are not yet clear.
4.2. Pif1 family
The Pif1 family of proteins is a set of SF1-type DNA helicases that
are conserved among all eukaryotes and translocate along ssDNA in
the 5′-to-3′ direction. Pif1 family members have been shown to haveroles in the maintenance of both mitochondrial and nuclear DNA,
including important roles at telomeres. In S. cerevisiae there are two
Pif1 family members, Pif1 and Rrm3, but most other eukaryotes have
only one Pif1 homolog [175].
As ﬁrst shown in S. cerevisiae, Pif1 proteins negatively regulate
telomerase activity by removing telomerase complexes from telomere
ends [77,176]. In vitro, yeast and human Pif1 limit the processivity of
telomerase [177]. In vivo, yeast pif1 deletion leads to a telomerase-
dependent increase in telomere length, whereas overexpression of
yeast Pif1 shortens telomeres and inhibits the occupancy of telomere
ends by telomerase [77]. Overexpression of human Pif1 in telomerase-
positive HT1080 cells also reportedly shortens telomeres [177]. The
ability of yeast Pif1 to inhibit telomerase activity was recently found to
depend on its interaction with the Est2 subunit of the telomerase
holoenzyme [178]. This ﬁnding takenwith the demonstration that Pif1
has a preference to unwind forked RNA–DNA hybrids, where the DNA
strand has a 5′ overhang and thus acts as the loading strand [179],
leads to the following model. Pif1 is recruited to telomere ends
through its interaction with Est2, and it then selectively unwinds the
RNA–DNA hybrid formed between the TLC1 telomerase template RNA
and the associated telomere DNA end, thus limiting the activity of
telomerase. An important corollary function to Pif1 action at
telomeres is its inhibition of the “healing” of DSBs by telomerase.
Such telomerase-mediated healing is stimulated over 200-fold by pif1
deletion in S. cerevisiae [180]. By preventing the conversion of DSBs to
de novo telomeres, Pif1 allows cells to exert appropriate checkpoint
responses to breaks and to then repair them by HR or NHEJ, thus
promoting genome stability. Surprisingly, Snow and coworkers
recently found that mouse Pif1p, although able to bind the catalytic
subunit of telomerase (TERT), does not inhibit telomerase activity in
vitro, and that murine cells from mice lacking Pif1 had normal
telomere lengths, sensitivity to DNA damaging agents, and gross
chromosome stability, even after successive generations of breeding in
two different strain backgrounds [181]. More work is needed to
determine if the unanticipated mouse results might be explained by
redundant helicases or by differences in mouse telomere length or
telomerase regulation.
Pif1 may also play additional roles at telomeres. For example, Pif1
has recently been found to be important for one pathway of Okazaki
fragment cleavage, and so it has been proposed to also play a role in
removing the terminal RNA primer at the start of the last telomeric
Okazaki fragment [76]. In addition, deletion of the nuclear form of Pif1
suppresses the growth defect of cdc13-1 mutants at non-permissive
temperatures [182,183]. A mutation in the TLC1 telomerase template
RNA that disrupts optimal association of telomerasewith the telomere
(tlc1Δ48) exacerbates the temperature sensitivity of cdc13-1mutants,
suggesting that pif1 deletion might enhance telomere capping by
increasing the amount of telomerase bound at the telomere. However,
it is also possible that absence of Pif1 could stabilize telomere
secondary structures (e.g. G-quadruplexes) that might impede
exonucleases.
The yeast Rrm3 protein appears to function primarily to promote
DNA replication. Replication fork progression is slowed at numerous
sites in cells lacking Rrm3, including the ribosomal DNA (rDNA), tRNA
genes, centromeres, silent mating loci, subtelomeres and telomeres
[60,184]. Increased replication pausing in rrm3 mutants is associated
with increased levels of DSBs and ectopic recombination, and
enhanced dependence on factors that assist in DNA repair and in
restarting collapsed replication forks, such as Mec1, and the Mre11/
Rad50/Xrs2 and Sgs1/Top3/Rmi1 complexes [185]. One indication of
how Rrm3 promotes fork progression is that it moves with the
replication apparatus and can associate physically with PCNA and DNA
polymerase epsilon [186,187]. The DNA sites of slowed replication in
rrm3 mutants are bound by non-nucleosomal protein complexes,
e.g. Fob1 at the rDNA, TFIIIc at tRNA genes, Rap1 at silent mating loci,
and the Sir2/3/4 complex at telomeres [184,188]. Deletion of Fob1 or
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in a site-speciﬁc fashion in rrm3 mutants, and deletion of Sir proteins
also has a modest effect on pausing at telomeres. This indicates that
Rrm3 might help remove particular chromatin proteins to facilitate
passage of the replication fork, although it might also function to
unwind DNA secondary structures. It is noteworthy that tlc1mutants,
which lack the telomerase RNA template and thus telomerase activity,
lose replicative capacity at a rate that is unaffected by Rrm3, indicating
that any increased telomere damage in rrm3 mutants is efﬁciently
repaired by backup pathways and thus does not accelerate telomere
loss in the absence of telomerase [155].
4.3. FANCJ family
The FANCJ family of DNA helicases are SF2 5′–3′ helicases, and
includemammalian FANCJ and RTEL, and C. elegansDOG-1 and RTEL-1
[189,190]. FANCJ was ﬁrst identiﬁed as being mutated in the germline
of early-onset breast cancer patients, and was then found to be
mutated in rare cases of the Fanconi anemia genome instability
disorder [191,192]. Among the FANCJ family of helicases, RTEL
(Regulator of telomere length) has the clearest roles in telomere
biology. It was originally implicated in telomere homeostasis follow-
ing crosses between the Mus musculus and Mus spretus species of
mice, which have long and short telomeres, respectively. The shorter
Mus spretus telomeres are rapidly elongated in the derived F1 progeny
of suchmatings, and the responsible dominant and trans-acting factor
was mapped to a ﬁve cM area of chromosome 2 of Mus musculus by
Zhu et al. [193]. The Lansdorp group later identiﬁed this factor as RTEL
[194]. RTEL is most highly expressed in rapidly dividing tissues and
upon differentiation. Consistent with this, Rtel−/− ES cells have a
striking defect in embryoid body formation and display a variety of
chromosomal abnormalities, the most prominent of which are
chromosomal end-to-end fusions lacking detectable telomeric signal
at the fusion site.
The mechanism through which RTEL maintains telomere integrity
is unknown, but recently the human helicase was shown to disrupt
preformed D-loops in vitro, similar to the S. cerevisiae Srs2 helicase
[189,195]. Taken together with the ﬁndings that C. elegans worms
lacking RTEL-1 and human cells with siRNA-mediated knockdown of
RTEL each show signs of elevated recombination, it appears that RTEL
suppresses HR. This led to the suggestion that RTEL might prevent t-
loop HR events leading to telomere losses (Fig. 5), or alternatively it
might unwind t-loops to enable access of telomerase to the telomere
end. It is unlikely that the latter mechanisms alone could explain all of
the telomere defects because evenmicewith null alleles of telomerase
require several generations of telomere shortening before telomere
fusions occur. An earlier suggestion that RTEL might instead maintain
telomeres by unwinding G-quadruplexes was based on its homology
to C. elegans DOG-1, because dog-1 mutants show a striking and
selective loss genome-wide of sequences having G-quadruplex
forming potential [196]. However, RTEL is a closer homologue of
RTEL-1, and rtel-1 mutant worms do not suffer from similar deletions
[189]. Furthermore, dog-1 mutants do not suffer deletions at
telomeres, although this may be because the C. elegans telomere
repeat, (TTAGGC)n, has relatively low G-quadruplex forming potential
[197]. In addition, the closest human homolog of DOG-1, FANCJ,
unwinds G-quadruplexes in vitro and protects human cells from the
toxicity of the G-quadruplex small molecule ligand telomestatin,
arguing that perhaps DOG-1 and FANCJ are the members of the FANCJ
helicase family that process G-quadruplexes [198]. Therefore, these
ﬁndings make it unlikely that RTEL resolves telomere G-quadruplexes,
although the ability of the protein to unwind G-quadruplexes has yet
to be tested directly. It is also not known whether human FANCJ plays
any roles in telomere maintenance. Further study should clarify the
mechanisms by which this important family of helicases helps
maintain telomeres and overall genome stability.5. Conclusion
The importance of telomeres for the maintenance of genome
stability and the pathogenesis of age-relateddegenerative diseases and
cancer is becoming increasingly apparent. Helicases are critical
regulators of several aspects of telomere metabolism, including
telomere replication and recombination, end-processing and capping,
extension by telomerase, and responses to uncapped telomeres.
Werner syndrome is the human disease most likely to reﬂect the
importance of telomere maintenance by helicases, although further
work is needed to determine if telomeres are indeed the critical target
of WRN in preventing age-related pathology and to demonstrate
precisely how WRN maintains telomeres. Biochemical and genetic
studies indicate that non-canonical DNA structures, including t-loops
and G-quadruplexes, likely represent important substrates for heli-
cases at telomeres, and these structures might provide targets for
manipulating telomere function. Given the complexities of telomere
processing and maintenance and the large number of helicases
involved, as well as the lack of any apparent helicase that is dedicated
to only a telomere target, targeting helicases to selectively manipulate
telomere functionwill not be a simple task. Prospects for DNAhelicases
as therapeutic targets have been well reviewed recently elsewhere
[199]. As more is learned about telomere form and function and their
modulation by helicases, one can envision means by which these
fascinating structures at the end of our chromosomes can be
manipulated to the beneﬁt of human health.
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